May I ask if your institution has a policy/position on evaluating and off
setting risks associated with PI initiated Clinical Trials? Any
insight/comments is appreciated.

Patti Manheim
Associate Director
Office of Research Services
Office of the Vice Chancellor for Research
University of Illinois at  Chicago
1737 West Polk Street, 305D AOB
Chicago, Illinois 60612-7227
(312) 996-9405 Direct line (312) 996-9005 Fax line
http://www.research.uic.edu/proposals
xxxxxx@uic.edu

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================